“Living Drug Factory” May be the Future Treatment for Chronic Diseases that Require Hormone Injections like Diabetes
source: pixabay.com

“Living Drug Factory” May be the Future Treatment for Chronic Diseases that Require Hormone Injections like Diabetes

  A person with diabetes is not able to properly make or use insulin well. Advancements in science are now seriously looking at updating and perfecting ways to help people…

Continue Reading “Living Drug Factory” May be the Future Treatment for Chronic Diseases that Require Hormone Injections like Diabetes
New Research Identifies Protein Epitope Targeted in Kawasaki Disease Immune Response
Sourced from publicdomainpictures.net (https://www.publicdomainpictures.net/en/view-image.php?image=275669&picture=chemical-research)

New Research Identifies Protein Epitope Targeted in Kawasaki Disease Immune Response

  According to new research from the Journal of Infectious Diseases, a new protein epitope has been discovered while testing the immune response of people with Kawasaki Disease. Kawasaki Disease, also…

Continue Reading New Research Identifies Protein Epitope Targeted in Kawasaki Disease Immune Response
Coronavirus: Could Medical Rationing Put the Chronically Ill/Disabled in Danger?
source: pixabay.com

Coronavirus: Could Medical Rationing Put the Chronically Ill/Disabled in Danger?

In a story written for The Washington Post, Jessica Slice writes about a frightful predicament for patients with chronic illnesses that cause disability. Jessica lives with dysautonomia and hypermobile Ehlers-Danlos…

Continue Reading Coronavirus: Could Medical Rationing Put the Chronically Ill/Disabled in Danger?
FDA Approves a Treatment for Neurofibromatosis Type 1 for the First Time Ever
source: pixabay.com

FDA Approves a Treatment for Neurofibromatosis Type 1 for the First Time Ever

A press release from the US Food and Drug Administration (FDA) recently announced the approval of the drug selumetinib (marketed as Koselugo) for the treatment of patients aged two years…

Continue Reading FDA Approves a Treatment for Neurofibromatosis Type 1 for the First Time Ever
Sex and Age Discrimination Could be Impeding Scientific Research for Conditions Like Cushing Syndrome
source: pixabay.com

Sex and Age Discrimination Could be Impeding Scientific Research for Conditions Like Cushing Syndrome

NICHD The NICHD is the The Eunice Kennedy Shriver National Institute of Child Health and Human Development, one of the National Institutes of Health (NIH). It is the center for…

Continue Reading Sex and Age Discrimination Could be Impeding Scientific Research for Conditions Like Cushing Syndrome
Close Menu